Brief: DMK Pharmaceuticals Files For Chapter 11 Bankruptcy In The U.S. - Court Filing
03/02/2024 01:01
Feb 2 (Reuters) - DMK Pharmaceuticals Corp DMK.O :
* DMK PHARMACEUTICALS FILES FOR CHAPTER 11 BANKRUPTCY IN THE
U.S.
- COURT FILING
* DMK PHARMACEUTICALS LISTS ESTIMATED ASSETS AND LIABILITIES
BOTH
IN THE RANGE OF $10 MILLION TO $50 MILLION- COURT FILING
Source text for Eikon: ID:
Further company coverage: DMK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DMK Pharmaceuticals
See all newsBrief: Dmk Pharmaceuticals Corp Says Ebrahim Versi Resigned As Chairman
Brief: ZMI Pharma Finalized Acquisition Of All Strategic Assets Necessary To Manufacture Zimhi From Dmk Pharma
Brief: DMK Pharmaceuticals Files For Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Dmk Pharmaceuticals Regains Full Rights To Commercialize Zimhi
Brief: DMK Pharmaceuticals Regains Full Rights From US Worldmeds For Symjepi And Provides Corporate Update